The Effect of Epicardial Fat on the Right and Left Ventricular Function in Subjects with Various Etiological Types of Pulmonary Arterial Hypertension

1. Thenappan T, Ormiston M, Ryan J, Archer S. Pulmonary arterial hypertension: pathogenesis and clinical management. BMJ. 2018;360:j5492.10.1136/bmj.j5492688997929540357Search in Google Scholar

2. Rabinovitch M, Guignabert C, Humbert M, Nicolls MR. Inflammation and Immunity in the Pathogenesis of Pulmonary Arterial Hypertension. Circulation Research. 2014;115:165-175.10.1161/CIRCRESAHA.113.301141409714224951765Search in Google Scholar

3. El Chami H, Hassoun PM. Immune and Inflammatory Mechanisms in Pulmonary Arterial Hypertension. Progress in Cardiovascular Diseases. 2012;55:218-228.10.1016/j.pcad.2012.07.006345918023009917Search in Google Scholar

4. Ryan JJ, Archer SL. The Right Ventricle in Pulmonary Arterial Hypertension: Disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure. Circulation Research. 2014;115:176-188.10.1161/CIRCRESAHA.113.301129411229024951766Search in Google Scholar

5. Naejie R, Manes A. The right ventricle in pulmonary arterial hypertension. European Respiratory Review. 2014;23:476-487.10.1183/09059180.0000741425445946Search in Google Scholar

6. Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D34-41.10.1016/j.jacc.2013.10.02924355639Search in Google Scholar

7. Engelfriet P, Meijboom F, Boersma E, Tijssen J, Mulder B. Repaired and open atrial septal defects type II in adulthood: an epidemiological study of a large European cohort. Int J Cardiol. 2008;126:379-385.10.1016/j.ijcard.2007.04.04417586067Search in Google Scholar

8. Post MC. Association between pulmonary hypertension and an atrial septal defect. Netherlands Heart Journal. 2013;21:331-332.10.1007/s12471-013-0432-9372238823737246Search in Google Scholar

9. Damy T, Goode KM, Kallvikbacka-Bennett A, et al. Determinants and prognostic value of pulmonary arterial pressure in patients with chronic heart failure. Eur Heart J. 2010;31:2280-2290.10.1093/eurheartj/ehq24520693169Search in Google Scholar

10. Delgado JF, Conde E, Sánchez V, et al. Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure. Eur J Heart Fail. 2005;7:1011-1016.10.1016/j.ejheart.2004.10.02116227139Search in Google Scholar

11. Hoeper MM. Pulmonary hypertension in collagen vascular disease. Eur Respir J. 2002;19:571-576.10.1183/09031936.02.0151200111936539Search in Google Scholar

12. Mukerjee D, St George D, Coleiro B, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis. 2003;62:1088-1093.10.1136/ard.62.11.1088175435314583573Search in Google Scholar

13. Fisher MR, Mathai SC, Champion HC, et al. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis &Rheumatology. 2006;54:3043-3050.10.1002/art.2206916947776Search in Google Scholar

14. Benedek T, Opincariu D, Rat N, Hodas R, Mester A, Benedek I. The Assessment of Epicardial Adipose Tissue in Acute Coronary Syndrome Patients. A Systematic Review. Journal of Cardiovascular Emergencies. 2017;3:18-29.10.1515/jce-2017-0003Search in Google Scholar

15. Mahabadi A, Berg M, Lehmann N, et al. Association of Epicardial Fat With Cardiovascular Risk Factors and Incident Myocardial Infarction in the General Population: The Heinz Nixdorf Recall Study. J Am Coll Cardiol. 2013;61:1388-1395.10.1016/j.jacc.2012.11.06223433560Search in Google Scholar

16. Torres T, Bettencourt N, Mendonça D, et al. Epicardial adipose tissue and coronary artery calcification in psoriasis patients. J Eur Acad Dermatol Venereol. 2015;29:270-277.10.1111/jdv.1251624750319Search in Google Scholar

17. Lima-Martinez MM, Campo E, Salazar J, et al. Epicardial fat thickness as cardiovascular risk factor and therapeutic target in patients with rheumatoid arthritis treated with biological and nonbiological therapies. Arthritis. 2014;2014:782850.10.1155/2014/782850427669625574390Search in Google Scholar

18. Long BD, Stojanovska J, Brown R, Attilli A, Jackson E, Ognenovski V. Increased Epicardial Fat Volume Is Independently Associated with the Presence and Severity of Systemic Sclerosis. Acad Radiol. 2017;24:1473-1481.10.1016/j.acra.2017.07.003572527028847640Search in Google Scholar

19. Kaplan O, Kurtoglu E, Gozubuyuk G, et al. Epicardial adipose tissue thickness in patients with chronic obstructive pulmonary disease having right ventricular systolic dysfunction. Eur Rev Med Pharmacol Sci. 2015;19:2461-2467.Search in Google Scholar

20. Gul I, Zungur M, Aykan A, et al. The relationship between GRACE score and Epicardial Fat thickness in non-STEMI Patients. Arq Bras Cardiol. 2016;106:194-200.10.5935/abc.20160024481127426885974Search in Google Scholar

21. Ozcan F, Turak O, Canpolat U, et al. Association of epicardial fat thickness with TIMI risk score in NSTEMI/USAP patients. Herz. 2013;39:755-760.10.1007/s00059-013-3914-z23903366Search in Google Scholar

22. Wang T, Liu Q, Liu C, et al. Correlation of Echocardiographic Epicardial Fat Thickness with Severity of Coronary Artery Disease in Patients with Acute myocardial infarction. Echocardiography. 2014;31:1177-1181.10.1111/echo.1254524645963Search in Google Scholar

23. Mazurek T, Zhang L, Zalewski A, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108:2460-2466.10.1161/01.CIR.0000099542.57313.C514581396Search in Google Scholar

24. Fatma E, Bunyamin K, Savas S, et al. Epicardial fat thickness in patients with rheumatoid arthritis. African Health Sciences. 2015;15:489-495.10.4314/ahs.v15i2.23448047826124795Search in Google Scholar